Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview to discover how groundbreaking gene therapy technology could… [Read More]
American Gene Technologies® Chief Medical Officer Honored by UCSF Endowment for HIV Dermatology and LGBTQ Health Research
Dr. Marcus Conant Named in UCSF’s Commitment to Pave Way for Next Generation of HIV Researchers American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, congratulates Dr. Marcus… [Read More]
From Lab to Launch Podcast: Testing a Gene Therapy to Potentially Cure HIV & Fundamentally Change Healthcare with Jeff Galvin
Have a listen. https://www.americangene.com/wp-content/uploads/2022/09/testing-a-gene-therapy-to-cure-hiv-fundamentally-change-healthcare-with-jeff-galvin-of-american-gene-technologies.mp3 From Lab to Launch by Qualio Jeff is the CEO and founder of American Gene Technologies®. He earned his BA degree in Economics from Harvard and… [Read More]
Queerty: Gay men are the “canary in the coal mine” of future pandemics, warns doc seeking HIV cure
Original post on queerty.com By David Hudson The trial of a potential HIV cure is underway. The scientists involved hope for initial results toward the end of the year. One… [Read More]
American Gene Technologies® Welcomes Barry H. Wells, M.D., as Head of Business Development
Dr. Wells’ promotion comes as the company’s HIV clinical trial progresses American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head… [Read More]
Unboxing Biotech Analyst Report: The Foundation Behind a Potential HIV Cure
Download the Report The exact origins of Human Immunodeficiency Virus (HIV) are not precisely known, but researchers theorize that the virus may have originated in chimpanzees,1and then crossed to humans… [Read More]
American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals
Beginning the analytic treatment interruption is a pivotal step to potentially demonstrating a gene therapy cure for HIV. American Gene Technologies, a clinical-stage biotechnology company, has reached a turning point… [Read More]
The Baltimore Sun: Maryland Might Lose Out on a New $1 Billion Federal Medical Research Accelerator
Original post on baltimoresun.com By Giacomo Bologna and Meredith Cohn Baltimore Sun At his State of the Union speech in March, President Joe Biden urged Congress to fund a new federal… [Read More]
CityBiz: American Gene Technologies® Appoints Dr. Jeff Boyle as Chief Science Officer
Original post on citybiz.co American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer. Dr. Boyle comes to the post with deep biotechnology expertise which will… [Read More]
ABC7 News: Progress in HIV cure: AGT™ hopes to have a ‘functionally cured patient by next summer’
Original post on WJLA.com We have an update in what developers hope will be an HIV cure, a story we’ve been following for more than a year now. A… [Read More]
ABC7 News: ‘I see amazing momentum.’ Efforts to find HIV cure are speeding up in Maryland
Original post on WJLA.com The efforts to find a functional cure for HIV are speeding up for one Maryland company after the Data Safety and Monitoring Board found no serious,… [Read More]
American Gene Technologies® Appoints Dr. Jeff Boyle as Chief Science Officer
Dr. Boyle’s biotech and intellectual property expertise strengthen the team as the company proceeds to next phase of its HIV cure clinical trial American Gene Technologies, a clinical-stage biotechnology company,… [Read More]
